4 recruiting. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Recruiting 4 |
Follow Social Behavior: new trials by email Literature Review of Social Behavior trials Research Report on Social Behavior
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Predictors of Improvements in Irritability and Aggression in Children With ADHD Treated With CNS Stimulants CNS Stimulant, Placebo, CNS Stimulant open label first phase - ADHD - Attention Deficit Disorder With Hyperactivity, Irritability | Phase 4 | Recruiting | Milton S. Hershey Medical Center | 136 | 2026-03-05 | 2026-04-20 |
| Mycophenolate-Based Therapy for Kidney Transplant Recipients Without HLA-DQ Mismatch Withdrawal of calcineurin-inhibitor, continue on concentration-controlled mycophenolate mofetil and corticosteroids. - Kidney Transplantation | Phase 4 | Recruiting | University Hospital, Antwerp | 20 | 2024-08-20 | 2024-08-21 |
| Empagliflozin Treatment in Kidney Transplant Recipients Empagliflozin - Kidney Transplant, Chronic Kidney Disease | Phase 4 | Recruiting | VA Office of Research and Development | 264 | 2024-04-05 | 2026-04-21 |
| Allograft Dysfunction in Heart Transplant Regadenoson - Heart Transplant Failure and Rejection | Phase 4 | Recruiting | Paul Kim | 376 | 2019-10-01 | 2026-05-01 |
Rejection, Psychology (3) · Aggression (1) · Attention Deficit Disorder with Hyperactivity (1) · Diabetes Mellitus (1) · Proteinuria (1) · Renal Insufficiency (1) · Renal Insufficiency, Chronic (1)
Behavior (4) · Aberrant Motor Behavior in Dementia (1) · Attention Deficit and Disruptive Behavior Disorders (1) · Behavioral Symptoms (1) · Chronic Disease (1) · Disease Attributes (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Glucose Metabolism Disorders (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Mental Disorders (1) · Metabolic Diseases (1)
Adrenal Cortex Hormones (1) · Central Nervous System Stimulants (1) · Clinical Trials, Phase II as Topic (1) · empagliflozin (1) · regadenoson (1)
Milton S. Hershey Medical Center (1) · Paul Kim (1) · University Hospital, Antwerp (1) · VA Office of Research and Development (1)
United States (3) · Belgium (1)
Hans de Fijter, MD PhD (1) · Paul Kim, MD (1) · Rachel Hellemans, MD PhD (1) · Roslyn B Mannon, MD (1)
PMID 11693758, PMID 11943259, PMID 16890123, PMID 18551063, PMID 19284612, PMID 20413602, PMID 20643330, PMID 21555100, PMID 21962016, PMID 24355800, PMID 24457279, PMID 3308166